COVID-19 Rapid Test Kits Market Report 2026

COVID-19 Rapid Test Kits Market Overview

• COVID-19 Rapid Test Kits market size has reached to $67.38 billion in 2025 • Expected to grow to xx billion in 2030 at a compound annual growth rate (CAGR) of xx% • Growth Driver: Healthcare Expenditure's Impact Driving The COVID-19 Rapid Test Kits Market • Market Trend: Advancements in COVID-19 Testing Kaneka Corporation's New Antigen Rapid Test Kit • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under COVID-19 Rapid Test Kits Market?

The COVID-19 rapid test kits are simple to use devices that offer prompt results, typically in 20 minutes or less. The COVID-19 rapid test kits are either rapid antigen test kits or rapid antibody test kits manufactured by the entities that manufacture in-vitro rapid diagnostic tests in the medical equipment industry. The COVID-19 rapid test kits market covered in this report is segmented by test type into rapid antigen test, rapid antibody test, and others. The rapid antigen test kits are used to detect the antigens related to the COVID-19 virus. It is also segmented by kit type into equipment and extraction kits, and reagents and by specimen type into nasopharyngeal swabs, oropharyngeal swabs, nasal swabs, blood samples, and others. The various end-users are hospitals and clinics, diagnostic laboratories, home care, and others.

Global COVID-19 Rapid Test Kits Market Segmentation

1) By Test Type: RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Other Test Types 2) By Specimen Type: Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood, Others 3) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End-Users Subsegments: 1) By RT PCR Test: Conventional RT PCR Tests, Real-Time RT PCR Tests, Automated RT PCR Systems 2) By Rapid Antigen Test: Nasal Swab Antigen Tests, Saliva-Based Antigen Tests, Lateral Flow Assays 3) By Rapid Antibody Test: IgM Or IgG Rapid Tests, Lateral Flow Serological Tests, Enzyme-Linked Immunosorbent Assay (ELISA) Kits 4) By Other Test Types: Combination Tests, Molecular Diagnostic Tests, Home Test Kits

What Is The Driver Of The COVID-19 Rapid Test Kits Market?

The rising healthcare expenditure is anticipated to drive the expansion of the COVID-19 rapid test kits market in the future. Healthcare expenditure refers to spending on healthcare costs and represents the total amount of money spent on healthcare-related goods and services within a given healthcare system or economy. Healthcare expenditure plays a crucial role in supporting the development, accessibility, and of COVID-19 rapid test kits. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), the US-based federal agency, National Health Expenditure (NHE) grew 7.5% to $4.9 trillion in 2023, or $14,570 per person, and accounted for 17.6% of Gross Domestic Product (GDP). Hospital expenditures grew 10.4% to $1,519.7 billion in 2023, faster than the 3.2% growth in 2022. Therefore, rising healthcare expenditure is driving the growth of the COVID-19 rapid test kits industry.

Key Players In The Global COVID-19 Rapid Test Kits Market

Major companies operating in the covid-19 rapid test kits market are Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Quidel Corporation, DiaSorin S.p.A., Mylab Discovery Solutions, Beijing Jinwofu Bioengineering Technology Company, Zhejiang Orient Gene Biotech Co. Ltd, Transasia Bio Medicals, Vanguard Diagnostics, SD Biosensor, Getein Biotech, Hangzhou Biotest Biotech, Boditech Med Inc, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Vivacheck Lab, Fujirebio, Atomo Diagnostics, Senova, CerTest Biotec, Omega Diagnostics, Abingdon Health, Novacyt Group, BioMaxima S.A, SensDx S.A, OraSure Technologies Inc, Sorrento Therapeutics, Monocent Inc, Aurora Biomed, Hologic, Mesa Biotech, Healgen Scientific Limited Liability Company, NTBIO Diagnostics, Motologic, ACRO Biotech, Cellex Inc, Advagen Biotech Ltd, BioMedomics, CapeBio

Global COVID-19 Rapid Test Kits Market Trends and Insights

Major companies operating in the COVID-19 Rapid Test Kits market are developing new products, such as Antigen Rapid Test Kits, to provide faster and more accurate detection of the virus, helping to control the spread of infections efficiently. Antigen Rapid Test Kits detect viral proteins related to infections like COVID-19, providing results within 15-30 minutes from a nasal or throat swab. While less sensitive than PCR tests, they are effective for quick screening in large populations. For instance, in June 2023, Kaneka Corporation, a Japan-based chemical manufacturing company, launched KANEKA Immunochromatography Flu A/B and SARS-CoV-2 Ag. This test kit offers rapid and accurate detection of COVID-19 and influenza viruses from a single nasal swab sample, providing results in about ten minutes. Its user-friendly design eliminates the need for specialized equipment, making it accessible for both medical facilities and self-testing scenarios. Additionally, the kit's capability to detect multiple viruses simultaneously enhances its utility in clinical settings, facilitating timely diagnosis and appropriate treatment decisions.

What Are Latest Mergers And Acquisitions In The COVID-19 Rapid Test Kits Market?

In June 2023, Avacta, a UK-based biotechnology company acquired Coris Bioconcept for an undisclosed amount. With this acquisition, Avacta aims to expand its diagnostics portfolio providing innovative solutions to the healthcare industry. Coris Bioconcept is a Belgium-based company that manufactures COVID-19 rapid test kits.

Regional Outlook

North America was the largest region in the COVID-19 rapid test kits market in 2025. Western Europe was the second largest region in the global COVID-19 rapid test kits market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the COVID-19 Rapid Test Kits Market?

The COVID-19 rapid test kits market consists of sales of molecular test kits and antigen test kits. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.